Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Himalayan Cordyceps (Cordyceps sinensis) contains polysaccharides, cordycepin, and adenosine that modulate immune cytokines and enhance cellular energy metabolism through ATP production optimization. This parasitic fungus demonstrates nephroprotective and anti-fatigue effects by inhibiting TGF-β1-Smad signaling and upregulating antioxidant enzymes.
Reported Benefits (Provisional)
Origin & History
Himalayan Cordyceps, *Cordyceps sinensis*, is a unique entomopathogenic fungus native to the high-altitude regions of the Himalayas, including Nepal, Bhutan, and Tibet. It thrives in cool, mountainous environments with low oxygen levels and nutrient-rich soils. Revered in traditional Himalayan medicine, it is valued for its adaptogenic properties, particularly its ability to enhance vitality, energy, and endurance.
Research Narrative (Provisional)
Numerous scientific studies, including human clinical trials, support *Cordyceps sinensis*'s efficacy in enhancing energy levels, improving athletic performance, and modulating immune function. Research also highlights its antioxidant and anti-inflammatory properties, validating its traditional uses for vitality and resilience.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Polysaccharides: Immunomodulatory and energy-supporting compounds. - Cordycepin: A unique nucleoside analog with anti-inflammatory and anti-tumor properties. - Amino Acids: Essential building blocks for protein synthesis. - Vitamins: B vitamins (e.g., B1, B2, B12) for energy metabolism, Vitamin D. - Minerals: Potassium, calcium, magnesium, zinc. - Adenosine: Supports ATP production and cardiovascular health.
Reported Mechanism (Provisional)
Cordyceps sinensis exerts its effects through polysaccharides and modified nucleosides like cordycepin and adenosine. These compounds modulate cytokine production by increasing IL-12, IFN-γ, and TNF-α while reducing pro-inflammatory IL-1β and IL-6. The bioactives also inhibit TGF-β1-Smad signaling pathways to reduce renal fibrosis and enhance NK cell activity and macrophage phagocytosis.
Clinical Narrative (Provisional)
Human clinical trials are extremely limited, with most evidence derived from animal and in vitro studies. A double-blind trial using CS-4 strain showed dose-dependent increases in mouse swimming endurance of 30% (low dose) to 73% (high dose) after 3 weeks. Small studies in chronic renal failure patients demonstrated improved kidney function and normalized T-cell ratios, while lupus mouse models showed enhanced survival and delayed proteinuria. Large-scale human randomized controlled trials with robust clinical endpoints are lacking and urgently needed to validate efficacy claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.